questionsmedicales.fr
Phénomènes physiologiques oculaires
Phénomènes physiologiques oculaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Examen de la vue
Optométrie
Fatigue oculaire
Tests de réfraction
Strabisme
Vision binoculaire
Sécheresse oculaire
Test de Schirmer
Pupille
Réaction pupillaire
Symptômes
5
Fatigue oculaire
Symptômes oculaires
Vision floue
Acuité visuelle
Infection oculaire
Symptômes infectieux
Allergies oculaires
Symptômes allergiques
Décollement de rétine
Perte de vision
Prévention
5
Fatigue oculaire
Prévention
Infection oculaire
Hygiène oculaire
Protection oculaire
Lunettes de soleil
Santé oculaire
Alimentation équilibrée
Allergies oculaires
Prévention des allergies
Traitements
5
Sécheresse oculaire
Larmes artificielles
Strabisme
Chirurgie oculaire
Fatigue oculaire
Lunettes anti-lumière bleue
Infection oculaire
Antibiotiques
Allergies oculaires
Antihistaminiques
Complications
5
Sécheresse oculaire
Lésions cornéennes
Infection oculaire
Cicatrices cornéennes
Fatigue oculaire
Exposition aux écrans
Allergies oculaires
Infections oculaires
Facteurs de risque
5
Sécheresse oculaire
Facteurs de risque
Strabisme
Antécédents familiaux
Infection oculaire
Lentilles de contact
Fatigue oculaire
Éclairage
Allergies oculaires
Pollution
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques oculaires : Questions médicales les plus fréquentes",
"headline": "Phénomènes physiologiques oculaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phénomènes physiologiques oculaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques oculaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Accommodation oculaire",
"alternateName": "Accommodation, Ocular",
"url": "https://questionsmedicales.fr/mesh/D000065",
"about": {
"@type": "MedicalCondition",
"name": "Accommodation oculaire",
"code": {
"@type": "MedicalCode",
"code": "D000065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.010"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Adaptation oculaire",
"alternateName": "Adaptation, Ocular",
"url": "https://questionsmedicales.fr/mesh/D000221",
"about": {
"@type": "MedicalCondition",
"name": "Adaptation oculaire",
"code": {
"@type": "MedicalCode",
"code": "D000221",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.020"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Adaptation à l'obscurité",
"alternateName": "Dark Adaptation",
"url": "https://questionsmedicales.fr/mesh/D003623",
"about": {
"@type": "MedicalCondition",
"name": "Adaptation à l'obscurité",
"code": {
"@type": "MedicalCode",
"code": "D003623",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.020.371"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Image consécutive",
"alternateName": "Afterimage",
"url": "https://questionsmedicales.fr/mesh/D000360",
"about": {
"@type": "MedicalCondition",
"name": "Image consécutive",
"code": {
"@type": "MedicalCode",
"code": "D000360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.040"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clignement",
"alternateName": "Blinking",
"url": "https://questionsmedicales.fr/mesh/D001767",
"about": {
"@type": "MedicalCondition",
"name": "Clignement",
"code": {
"@type": "MedicalCode",
"code": "D001767",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.152"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dominance oculaire",
"alternateName": "Dominance, Ocular",
"url": "https://questionsmedicales.fr/mesh/D023882",
"about": {
"@type": "MedicalCondition",
"name": "Dominance oculaire",
"code": {
"@type": "MedicalCode",
"code": "D023882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.264"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Potentiels évoqués visuels",
"alternateName": "Evoked Potentials, Visual",
"url": "https://questionsmedicales.fr/mesh/D005074",
"about": {
"@type": "MedicalCondition",
"name": "Potentiels évoqués visuels",
"code": {
"@type": "MedicalCode",
"code": "D005074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mouvements oculaires",
"alternateName": "Eye Movements",
"url": "https://questionsmedicales.fr/mesh/D005133",
"about": {
"@type": "MedicalCondition",
"name": "Mouvements oculaires",
"code": {
"@type": "MedicalCode",
"code": "D005133",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Convergence oculaire",
"alternateName": "Convergence, Ocular",
"url": "https://questionsmedicales.fr/mesh/D003290",
"about": {
"@type": "MedicalCondition",
"name": "Convergence oculaire",
"code": {
"@type": "MedicalCode",
"code": "D003290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fixation oculaire",
"alternateName": "Fixation, Ocular",
"url": "https://questionsmedicales.fr/mesh/D005403",
"about": {
"@type": "MedicalCondition",
"name": "Fixation oculaire",
"code": {
"@type": "MedicalCode",
"code": "D005403",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.253"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nystagmus physiologique",
"alternateName": "Nystagmus, Physiologic",
"url": "https://questionsmedicales.fr/mesh/D009760",
"about": {
"@type": "MedicalCondition",
"name": "Nystagmus physiologique",
"code": {
"@type": "MedicalCode",
"code": "D009760",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.378"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nystagmus optocinétique",
"alternateName": "Nystagmus, Optokinetic",
"url": "https://questionsmedicales.fr/mesh/D017120",
"about": {
"@type": "MedicalCondition",
"name": "Nystagmus optocinétique",
"code": {
"@type": "MedicalCode",
"code": "D017120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.378.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nystagmus optocinétique",
"alternateName": "Nystagmus, Optokinetic",
"url": "https://questionsmedicales.fr/mesh/D017120",
"about": {
"@type": "MedicalCondition",
"name": "Nystagmus optocinétique",
"code": {
"@type": "MedicalCode",
"code": "D017120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.378.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Poursuite oculaire",
"alternateName": "Pursuit, Smooth",
"url": "https://questionsmedicales.fr/mesh/D011698",
"about": {
"@type": "MedicalCondition",
"name": "Poursuite oculaire",
"code": {
"@type": "MedicalCode",
"code": "D011698",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.453"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Saccades",
"alternateName": "Saccades",
"url": "https://questionsmedicales.fr/mesh/D012438",
"about": {
"@type": "MedicalCondition",
"name": "Saccades",
"code": {
"@type": "MedicalCode",
"code": "D012438",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.350.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Effet consécutif figural",
"alternateName": "Figural Aftereffect",
"url": "https://questionsmedicales.fr/mesh/D005366",
"about": {
"@type": "MedicalCondition",
"name": "Effet consécutif figural",
"code": {
"@type": "MedicalCode",
"code": "D005366",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fréquence critique de fusion",
"alternateName": "Flicker Fusion",
"url": "https://questionsmedicales.fr/mesh/D005425",
"about": {
"@type": "MedicalCondition",
"name": "Fréquence critique de fusion",
"code": {
"@type": "MedicalCode",
"code": "D005425",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.370"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lumière éblouissante",
"alternateName": "Glare",
"url": "https://questionsmedicales.fr/mesh/D019466",
"about": {
"@type": "MedicalCondition",
"name": "Lumière éblouissante",
"code": {
"@type": "MedicalCode",
"code": "D019466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pression intraoculaire",
"alternateName": "Intraocular Pressure",
"url": "https://questionsmedicales.fr/mesh/D007429",
"about": {
"@type": "MedicalCondition",
"name": "Pression intraoculaire",
"code": {
"@type": "MedicalCode",
"code": "D007429",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.440"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Élimination lacrymale",
"alternateName": "Lacrimal Elimination",
"url": "https://questionsmedicales.fr/mesh/D066234",
"about": {
"@type": "MedicalCondition",
"name": "Élimination lacrymale",
"code": {
"@type": "MedicalCode",
"code": "D066234",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.540"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Absorption oculaire",
"alternateName": "Ocular Absorption",
"url": "https://questionsmedicales.fr/mesh/D065587",
"about": {
"@type": "MedicalCondition",
"name": "Absorption oculaire",
"code": {
"@type": "MedicalCode",
"code": "D065587",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flux optique",
"alternateName": "Optic Flow",
"url": "https://questionsmedicales.fr/mesh/D057849",
"about": {
"@type": "MedicalCondition",
"name": "Flux optique",
"code": {
"@type": "MedicalCode",
"code": "D057849",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Réfraction oculaire",
"alternateName": "Refraction, Ocular",
"url": "https://questionsmedicales.fr/mesh/D012029",
"about": {
"@type": "MedicalCondition",
"name": "Réfraction oculaire",
"code": {
"@type": "MedicalCode",
"code": "D012029",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Disparité rétinienne",
"alternateName": "Vision Disparity",
"url": "https://questionsmedicales.fr/mesh/D015357",
"about": {
"@type": "MedicalCondition",
"name": "Disparité rétinienne",
"code": {
"@type": "MedicalCode",
"code": "D015357",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.930"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision",
"alternateName": "Vision, Ocular",
"url": "https://questionsmedicales.fr/mesh/D014785",
"about": {
"@type": "MedicalCondition",
"name": "Vision",
"code": {
"@type": "MedicalCode",
"code": "D014785",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vision des couleurs",
"alternateName": "Color Vision",
"url": "https://questionsmedicales.fr/mesh/D055253",
"about": {
"@type": "MedicalCondition",
"name": "Vision des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D055253",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.124"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision mésopique",
"alternateName": "Mesopic Vision",
"url": "https://questionsmedicales.fr/mesh/D055255",
"about": {
"@type": "MedicalCondition",
"name": "Vision mésopique",
"code": {
"@type": "MedicalCode",
"code": "D055255",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.186"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Interaction entre les cônes et les bâtonnets",
"alternateName": "Rod-Cone Interaction",
"url": "https://questionsmedicales.fr/mesh/D055258",
"about": {
"@type": "MedicalCondition",
"name": "Interaction entre les cônes et les bâtonnets",
"code": {
"@type": "MedicalCode",
"code": "D055258",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.186.624"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Interaction entre les cônes et les bâtonnets",
"alternateName": "Rod-Cone Interaction",
"url": "https://questionsmedicales.fr/mesh/D055258",
"about": {
"@type": "MedicalCondition",
"name": "Interaction entre les cônes et les bâtonnets",
"code": {
"@type": "MedicalCode",
"code": "D055258",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.186.624"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision nocturne",
"alternateName": "Night Vision",
"url": "https://questionsmedicales.fr/mesh/D055254",
"about": {
"@type": "MedicalCondition",
"name": "Vision nocturne",
"code": {
"@type": "MedicalCode",
"code": "D055254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosphènes",
"alternateName": "Phosphenes",
"url": "https://questionsmedicales.fr/mesh/D010719",
"about": {
"@type": "MedicalCondition",
"name": "Phosphènes",
"code": {
"@type": "MedicalCode",
"code": "D010719",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision entoptique",
"alternateName": "Vision, Entoptic",
"url": "https://questionsmedicales.fr/mesh/D014788",
"about": {
"@type": "MedicalCondition",
"name": "Vision entoptique",
"code": {
"@type": "MedicalCode",
"code": "D014788",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.935.730"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Acuité visuelle",
"alternateName": "Visual Acuity",
"url": "https://questionsmedicales.fr/mesh/D014792",
"about": {
"@type": "MedicalCondition",
"name": "Acuité visuelle",
"code": {
"@type": "MedicalCode",
"code": "D014792",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.940"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sensibilité au contraste",
"alternateName": "Contrast Sensitivity",
"url": "https://questionsmedicales.fr/mesh/D015350",
"about": {
"@type": "MedicalCondition",
"name": "Sensibilité au contraste",
"code": {
"@type": "MedicalCode",
"code": "D015350",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.940.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Emmétropie",
"alternateName": "Emmetropia",
"url": "https://questionsmedicales.fr/mesh/D058453",
"about": {
"@type": "MedicalCondition",
"name": "Emmétropie",
"code": {
"@type": "MedicalCode",
"code": "D058453",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.940.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Champs visuels",
"alternateName": "Visual Fields",
"url": "https://questionsmedicales.fr/mesh/D014794",
"about": {
"@type": "MedicalCondition",
"name": "Champs visuels",
"code": {
"@type": "MedicalCode",
"code": "D014794",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14.950"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques oculaires",
"alternateName": "Ocular Physiological Phenomena",
"code": {
"@type": "MedicalCode",
"code": "D009799",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maxime Le Merdy",
"url": "https://questionsmedicales.fr/author/Maxime%20Le%20Merdy",
"affiliation": {
"@type": "Organization",
"name": "Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA. maxime@simulations-plus.com."
}
},
{
"@type": "Person",
"name": "Jessica Spires",
"url": "https://questionsmedicales.fr/author/Jessica%20Spires",
"affiliation": {
"@type": "Organization",
"name": "Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA."
}
},
{
"@type": "Person",
"name": "Viera Lukacova",
"url": "https://questionsmedicales.fr/author/Viera%20Lukacova",
"affiliation": {
"@type": "Organization",
"name": "Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA."
}
},
{
"@type": "Person",
"name": "Ming-Liang Tan",
"url": "https://questionsmedicales.fr/author/Ming-Liang%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Food and Drug Administration, CDER/OGD/ORS/DQMM, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA."
}
},
{
"@type": "Person",
"name": "Liang Zhao",
"url": "https://questionsmedicales.fr/author/Liang%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Food and Drug Administration, CDER/OGD/ORS/DQMM, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques oculaires",
"item": "https://questionsmedicales.fr/mesh/D009799"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phénomènes physiologiques oculaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phénomènes physiologiques oculaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phénomènes physiologiques oculaires",
"description": "Comment évaluer la vision d'un patient ?\nQuels tests pour détecter la fatigue oculaire ?\nComment diagnostiquer un strabisme ?\nQuels examens pour la sécheresse oculaire ?\nComment détecter une anomalie de la pupille ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phénomènes physiologiques oculaires",
"description": "Quels sont les signes de la fatigue oculaire ?\nComment reconnaître une vision floue ?\nQuels symptômes d'une infection oculaire ?\nQuels signes d'une allergie oculaire ?\nComment identifier un décollement de rétine ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phénomènes physiologiques oculaires",
"description": "Comment prévenir la fatigue oculaire ?\nQuelles mesures pour éviter les infections oculaires ?\nComment protéger les yeux du soleil ?\nQuelles habitudes pour des yeux en bonne santé ?\nComment éviter les allergies oculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phénomènes physiologiques oculaires",
"description": "Quels traitements pour la sécheresse oculaire ?\nComment traiter un strabisme ?\nQuelles options pour la fatigue oculaire ?\nComment traiter une infection oculaire ?\nQuels traitements pour les allergies oculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phénomènes physiologiques oculaires",
"description": "Quelles complications d'un strabisme non traité ?\nQuels risques d'une sécheresse oculaire sévère ?\nQuelles complications d'une infection oculaire ?\nQuels effets d'une exposition prolongée aux écrans ?\nQuelles complications d'une allergie oculaire non traitée ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phénomènes physiologiques oculaires",
"description": "Quels facteurs augmentent le risque de sécheresse oculaire ?\nQuels sont les facteurs de risque du strabisme ?\nQuels facteurs de risque pour les infections oculaires ?\nQuels facteurs influencent la fatigue oculaire ?\nQuels facteurs de risque pour les allergies oculaires ?",
"url": "https://questionsmedicales.fr/mesh/D009799?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la vision d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision comme l'optométrie et l'examen de la rétine sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour détecter la fatigue oculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des tests de réfraction peuvent aider à diagnostiquer la fatigue oculaire."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer un strabisme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen clinique et des tests de vision binoculaire sont essentiels pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels examens pour la sécheresse oculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de Schirmer et des évaluations de la surface oculaire sont courants."
}
},
{
"@type": "Question",
"name": "Comment détecter une anomalie de la pupille ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen de la réaction pupillaire à la lumière et à l'accommodation est effectué."
}
},
{
"@type": "Question",
"name": "Quels sont les signes de la fatigue oculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des yeux secs, des démangeaisons et des maux de tête."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une vision floue ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vision floue se manifeste par une difficulté à voir clairement les objets proches ou éloignés."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une infection oculaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, douleur, écoulement et sensibilité à la lumière sont des signes d'infection."
}
},
{
"@type": "Question",
"name": "Quels signes d'une allergie oculaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les démangeaisons, larmoiements et rougeurs sont typiques des allergies oculaires."
}
},
{
"@type": "Question",
"name": "Comment identifier un décollement de rétine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des flashes lumineux, des ombres ou une perte de vision soudaine peuvent indiquer un décollement."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fatigue oculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prendre des pauses régulières lors de l'utilisation d'écrans et ajuster l'éclairage aide."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter les infections oculaires ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains et éviter de toucher les yeux sont des mesures préventives clés."
}
},
{
"@type": "Question",
"name": "Comment protéger les yeux du soleil ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter des lunettes de soleil avec protection UV est essentiel pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quelles habitudes pour des yeux en bonne santé ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'hydratation et des examens réguliers sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment éviter les allergies oculaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes connus et utiliser des filtres à air peut réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la sécheresse oculaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les larmes artificielles et les médicaments anti-inflammatoires sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "Comment traiter un strabisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des lunettes, des exercices oculaires ou une chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles options pour la fatigue oculaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des pauses régulières, des exercices oculaires et des lunettes anti-lumière bleue sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques topiques ou oraux sont souvent nécessaires pour traiter les infections."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les allergies oculaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques et des gouttes oculaires peuvent soulager les symptômes allergiques."
}
},
{
"@type": "Question",
"name": "Quelles complications d'un strabisme non traité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un strabisme non traité peut entraîner une amblyopie et des problèmes de perception de la profondeur."
}
},
{
"@type": "Question",
"name": "Quels risques d'une sécheresse oculaire sévère ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une sécheresse oculaire sévère peut causer des lésions cornéennes et une perte de vision."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une infection oculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections oculaires peuvent entraîner des cicatrices cornéennes et une perte de vision permanente."
}
},
{
"@type": "Question",
"name": "Quels effets d'une exposition prolongée aux écrans ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut causer des troubles de la vision, fatigue oculaire et sécheresse."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une allergie oculaire non traitée ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des allergies non traitées peuvent entraîner des infections et des lésions oculaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de sécheresse oculaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, l'utilisation prolongée d'écrans et certaines maladies comme le diabète augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du strabisme ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux, des troubles neurologiques et des problèmes de vision peuvent être des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les infections oculaires ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de lentilles de contact, une mauvaise hygiène et des allergies augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la fatigue oculaire ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le temps passé devant un écran, l'éclairage inapproprié et le manque de pauses sont des facteurs influents."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les allergies oculaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'exposition à des allergènes et la pollution sont des facteurs de risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 05/05/2025
Contenu vérifié selon les dernières recommandations médicales
└─
Accommodation oculaire
Accommodation, Ocular
D000065
-
G14.010
└─
Adaptation oculaire
Adaptation, Ocular
D000221
-
G14.020
└─
Image consécutive
Afterimage
D000360
-
G14.040
└─
Clignement
Blinking
D001767
-
G14.152
└─
Dominance oculaire
Dominance, Ocular
D023882
-
G14.264
└─
Potentiels évoqués visuels
Evoked Potentials, Visual
D005074
-
G14.330
└─
Mouvements oculaires
Eye Movements
D005133
-
G14.350
└─
Effet consécutif figural
Figural Aftereffect
D005366
-
G14.360
└─
Fréquence critique de fusion
Flicker Fusion
D005425
-
G14.370
└─
Lumière éblouissante
Glare
D019466
-
G14.400
└─
Pression intraoculaire
Intraocular Pressure
D007429
-
G14.440
└─
Élimination lacrymale
Lacrimal Elimination
D066234
-
G14.540
└─
Absorption oculaire
Ocular Absorption
D065587
-
G14.590
└─
Flux optique
Optic Flow
D057849
-
G14.700
└─
Réfraction oculaire
Refraction, Ocular
D012029
-
G14.760
└─
Disparité rétinienne
Vision Disparity
D015357
-
G14.930
└─
Vision
Vision, Ocular
D014785
-
G14.935
└─
Acuité visuelle
Visual Acuity
D014792
-
G14.940
└─
Champs visuels
Visual Fields
D014794
-
G14.950
└─└─
Adaptation à l'obscurité
Dark Adaptation
D003623
-
G14.020.371
└─└─
Convergence oculaire
Convergence, Ocular
D003290
-
G14.350.217
└─└─
Fixation oculaire
Fixation, Ocular
D005403
-
G14.350.253
└─└─
Nystagmus physiologique
Nystagmus, Physiologic
D009760
-
G14.350.378
└─└─
Poursuite oculaire
Pursuit, Smooth
D011698
-
G14.350.453
└─└─
Saccades
Saccades
D012438
-
G14.350.500
└─└─
Vision des couleurs
Color Vision
D055253
-
G14.935.124
└─└─
Vision mésopique
Mesopic Vision
D055255
-
G14.935.186
└─└─
Vision nocturne
Night Vision
D055254
-
G14.935.249
└─└─
Phosphènes
Phosphenes
D010719
-
G14.935.500
└─└─
Vision entoptique
Vision, Entoptic
D014788
-
G14.935.730
└─└─
Sensibilité au contraste
Contrast Sensitivity
D015350
-
G14.940.500
└─└─
Emmétropie
Emmetropia
D058453
-
G14.940.750
└─└─└─
Nystagmus optocinétique
Nystagmus, Optokinetic
D017120
-
G14.350.378.500
└─└─└─
Interaction entre les cônes et les bâtonnets
Rod-Cone Interaction
D055258
-
G14.935.186.624
2 publications dans cette catégorie
Affiliations :
Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA. maxime@simulations-plus.com.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Simulations Plus, Inc., 42505 10th Street West, Lancaster, California, 93534, USA.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Food and Drug Administration, CDER/OGD/ORS/DQMM, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Food and Drug Administration, CDER/OGD/ORS/DQMM, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, USA.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York, University at Buffalo 455 Kapoor Hall, Buffalo, NY, 14214-8033, USA.
Publications dans "Phénomènes physiologiques oculaires" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York, University at Buffalo 455 Kapoor Hall, Buffalo, NY, 14214-8033, USA. dshah4@buffalo.edu.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Ophthalmology Interest Group (OIG-UR), Neuroscience Research Group (NEUROS), Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Faculty of Medicine, Universidad de La Sabana, Chía, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Ophthalmology Interest Group (OIG-UR), Neuroscience Research Group (NEUROS), Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud,Universidad del Rosario, Bogotá, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Ophthalmology Service, Bayer S.A, Bogotá, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Ophthalmology Interest Group (OIG-UR), Neuroscience Research Group (NEUROS), Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud,Universidad del Rosario, Bogotá, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Ophthalmology Interest Group (OIG-UR), Neuroscience Research Group (NEUROS), Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia.
Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT), Escuela de Medicina y Ciencias de la Salud,Universidad del Rosario, Bogotá, Colombia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Australian Institute of Microbiology and Infection, University of Technology Sydney, Broadway, New South Wales, Australia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Australian Institute of Microbiology and Infection, University of Technology Sydney, Broadway, New South Wales, Australia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Australian Institute of Microbiology and Infection, University of Technology Sydney, Broadway, New South Wales, Australia.
Australian Centre for Genomic Epidemiological Microbiology, University of Technology Sydney, Broadway, New South Wales, Australia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Australian Institute of Microbiology and Infection, University of Technology Sydney, Broadway, New South Wales, Australia.
Australian Centre for Genomic Epidemiological Microbiology, University of Technology Sydney, Broadway, New South Wales, Australia.
Publications dans "Phénomènes physiologiques oculaires" :
1 publication dans cette catégorie
Affiliations :
Australian Institute of Microbiology and Infection, University of Technology Sydney, Broadway, New South Wales, Australia.
Publications dans "Phénomènes physiologiques oculaires" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...